KIF22 and esophageal squamous cell carcinoma: Enhanced miR-122 expression can downregulate KIF22 as a way to promote apoptosis and G0/G1 phase arrest in ESCC cells and significantly inhibit the malignant progression of ESCC cells by suppressing the ability of EMT to inhibit ESCC proliferation, migration and invasion [168].